KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Retained Earnings (2016 - 2025)

Jazz Pharmaceuticals has reported Retained Earnings over the past 16 years, most recently at $646.2 million for Q4 2025.

  • Quarterly Retained Earnings fell 42.68% to $646.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $646.2 million through Dec 2025, down 42.68% year-over-year, with the annual reading at $646.2 million for FY2025, 42.68% down from the prior year.
  • Retained Earnings was $646.2 million for Q4 2025 at Jazz Pharmaceuticals, up from -$569.9 million in the prior quarter.
  • Over five years, Retained Earnings peaked at $1.1 billion in Q4 2024 and troughed at -$785.6 million in Q1 2025.
  • The 5-year median for Retained Earnings is $768.3 million (2022), against an average of $364.6 million.
  • Peak annual rise in Retained Earnings hit 620.57% in 2022, while the deepest fall reached 229.22% in 2022.
  • Tracing JAZZ's Retained Earnings over 5 years: stood at $830.2 million in 2021, then fell by 11.64% to $733.6 million in 2022, then rose by 19.78% to $878.7 million in 2023, then grew by 28.3% to $1.1 billion in 2024, then plummeted by 42.68% to $646.2 million in 2025.
  • According to Business Quant data, Retained Earnings over the past three periods came in at $646.2 million, -$569.9 million, and $191.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.